To evaluate the dynamic alterations of Th2/Th1 for the prediction of clinical immunity and how it was related to 28 day-prognosis and ICU-acquired infections among critically ill patients of community-acquired severe sepsis with new onset.
Study Type
OBSERVATIONAL
Enrollment
85
Zhongda Hospital
Nanjing, Jiangsu, China
Th2/Th1 upon enrollment
The blood samples were collected for T helper 1 cells and T helper 2 cells populations measured by flow cytometry. All groups are needed.
Time frame: Day 0 after enrollment for community-acquired severe sepsis group and Day 0 after enrollment for the non-severe sepsis patients and heathy control group
Th2/Th1 on Day 3
populations measured by flow cytometry. Only community-acquired severe sepsis group is needed.
Time frame: Day 3 after enrollment for community-acquired severe sepsis group
Th2/Th1 on Day 7
populations measured by flow cytometry. Only community-acquired severe sepsis group is needed.
Time frame: Day 7 after enrollment for community-acquired severe sepsis group
28-day mortality for community-acquired severe sepsis group
Time frame: 28-day
ICU-acquired infection for community-acquired severe sepsis group
Time frame: 28-day
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.